Boiron SA-Strategy, SWOT and Corporate Finance Report

Boiron SA-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Findings

Detailed information on Boiron SA required for business and competitor intelligence needs

A study of the major internal and external factors affecting Boiron SA in the form of a SWOT analysis

An in-depth view of the business model of Boiron SA including a breakdown and examination of key business segments

Intelligence on Boiron SA’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Boiron SA, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons To Buy

Gain understanding of Boiron SA and the factors that influence its strategies

Track strategic initiatives of the company and latest corporate news and actions

Assess Boiron SA as a prospective partner, vendor or supplier

Support sales activities by understanding your customers’ businesses better

Stay up to date on Boiron SA’s business structure, strategy and prospects

Key Highlights

Boiron (or ‘the group’) is a France-based pharmaceutical group specializing in homeopathic medicines. The group primarily operates in Europe, North America and other regions of the world. It is headquartered in Messimy, France, and employed 3,723 people as on December 31, 2013.